Comparison of pro re nata versus Bimonthly Injection of Intravitreal Aflibercept for Typical Neovascular Age-Related Macular Degeneration

Publisher： Karger

E-ISSN： 1423-0267|238|1-2|17-22

ISSN： 0030-3755

Source： Ophthalmologica, Vol.238, Iss.1-2, 2017-04, pp. : 17-22

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

One-Year Outcomes of 1 + pro re nata versus 3 + pro re nata Intravitreal Aflibercept Injection for Neovascular Age-Related Macular Degeneration

By  

Ophthalmologica, Vol. 237, Iss. 2, 2017-02 ,pp. : 105-110

Karger

Access to resources Recommend Favorite

Outcomes when Switching from a pro re nata Regimen to a Treat and Extend Regimen Using Aflibercept in Neovascular Age-Related Macular Degeneration

By  

Ophthalmologica, Vol. 236, Iss. 4, 2016-12 ,pp. : 201-206

Karger

Access to resources Recommend Favorite

A Case of Sustained Intraocular Pressure Elevation after Multiple Intravitreal Injection of Ranibizumab and Aflibercept for Neovascular Age-Related Macular Degeneration

By  

Case Reports in Ophthalmology, Vol. 7, Iss. 1, 2016-04 ,pp. : 230-236

Karger

Access to resources Recommend Favorite

Bimonthly Ranibizumab for Neovascular Age-Related Macular Degeneration

By  

Ophthalmologica, Vol. 231, Iss. 2, 2013-12 ,pp. : 80-85

Karger

Access to resources Recommend Favorite

Fluctuations in Pigment Epithelial Detachment and Retinal Fluid Using a Bimonthly Treatment Regimen with Aflibercept for Neovascular Age-Related Macular Degeneration

By  

Ophthalmologica, Vol. 235, Iss. 1, 2016-0 ,pp. : 42-48

Karger

Access to resources Recommend Favorite